Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis

Ann Oncol. 2019 Jul 1;30(7):1179. doi: 10.1093/annonc/mdy535.
No abstract available

Publication types

  • Published Erratum